INVENTIVA, a company focusing on MASH therapies, held leadership conferences in New York City and Brussels.
8 reports, 2 independent
Updated Sep 8
Gone quiet
- Reports
- 8
- Developments
- 4
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
INVENTIVA, a company focusing on MASH therapies, held leadership conferences in New York City and Brussels.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.INVENTIVA announced clinical data at the Paris MASH Meeting.1 source
INVENTIVA, a MASH therapy company, held leadership conferences in NYC and Brussels.1 source
- INVENTIVA's lanifibranor development targets Mainland China and Taiwan, alongside stock listings.
- INVENTIVA is headquartered in France and conducts clinical trials in the US.
Keep exploring
The entities involved
-
INVENTIVA
company in the Czech Republic
-
mash
fast genome and metagenome distance estimation using MinHash
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- finanznachrichten.de
- GlobeNewswireInventiva to Participate in Upcoming September Investor Conferences Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva”
- GlobeNewswireInventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference Daix (France), New York City (New York, United States), August 11, 2025 – Inventiva (Euronext Paris an
- GlobeNewswireHalf-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), New York (New York, United States), July 31, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or
- GlobeNewswireInventiva Reports Preliminary 2025 First-Half Financial Information¹ Cash and cash equivalents at €122.1 million and €24.6 million in short-term deposits2 as of June 30, 2025 Revenues of €4.5 million
- Unknown outlet
- Unknown outlet